Eli Lilly Archives - Express Pharma

Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access, reveals GlobalData

Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData

Eli Lilly appoints Winselow Tucker as President and General Manager for India

GLP-1R gold rush: Emerging biotechs can challenge market leaders, says GlobalData

Eli Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program

Global Alzheimer’s disease market to reach $19.3 bn in 8MM by 2033

Eli Lilly’s Zepbound holds possibility to dominate obesity market

Lupin acquires Huminsulin from Eli Lilly

Race for approval of first oral GLP-1R drug in obesity intensifies with four in phase III trials: GlobalData

NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData